Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Laser navigation for radiofrequency ablation.

Zoltan Varro1, Julia K Locklin, Bradford J Wood

  • 1Warren G. Magnuson Clinical Center, Diagnostic Radiology Department, National Institutes of Health, Building 10, Room 1C660, Bethesda, MD 20892, USA.

Cardiovascular and Interventional Radiology
|September 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International multisociety Delphi consensus for liver tumour thermal ablation: margin assessment.

The Lancet. Oncology·2026
Same author

International multisociety Delphi consensus for liver tumour thermal ablation: procedural and practice standards.

The Lancet. Oncology·2026
Same author

Development and Validation of a Multimodal AI-Based Model for Predicting Post-Prostatectomy Treatment Outcomes from Baseline Biparametric Prostate MRI.

medRxiv : the preprint server for health sciences·2026
Same author

Evaluating Clinically Significant Prostate Cancer with Pathology-Registered Radiomics: A Multi-Reader Assessment Using Lesion Diameter-based Simplified Segmentations on MRI.

Academic radiology·2026
Same author

Antitumoral immunity induced by gel ethanol ablation to treat unresectable colorectal cancer metastases in the liver.

PloS one·2026
Same author

Tumor-Targeted IL-12 (PDS01ADC) with Hepatic Artery Infusion Pump Therapy for Colorectal Liver Metastases: Interim Analysis of a Non-randomized Phase II Trial.

JCO oncology advances·2026

Radiofrequency ablation (RFA) with laser guidance effectively treated kidney tumors in a patient with von Hippel Lindau (VHL) disease. This nephron-sparing approach ensured accurate tumor ablation, preserving renal function in a patient with limited kidney reserve.

Area of Science:

  • Nephrology
  • Oncology
  • Minimally Invasive Surgery

Background:

  • A 45-year-old male with von Hippel Lindau (VHL) disease presented with renal cell carcinoma.
  • The patient had a history of multiple partial nephrectomies, resulting in limited renal reserve.
  • Radiofrequency ablation (RFA) was selected as a nephron-sparing treatment option.

Observation:

  • A laser guidance device was employed to assist in radiofrequency ablation probe placement.
  • The goal was to reduce procedure time and enhance targeting accuracy.
  • The device facilitated precise needle placement for both kidney tumors.

Findings:

  • Both renal tumors were successfully located and targeted with a single needle pass.
  • Post-procedure CT scans confirmed accurate probe placement.

Related Experiment Videos

  • The imaging revealed an area of coagulation necrosis encompassing the treated tumors.

    • Implications:

    • Laser-guided RFA demonstrates potential as an accurate and nephron-sparing technique for VHL-associated renal tumors.
    • This method may be particularly beneficial for patients with compromised renal function.
    • Further research could explore the broader application of laser guidance in renal tumor ablation.